Sandip Kapadia
2018 - Intercept Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $228,735 |
|---|---|
| Option Awards | $393,544 |
| Salary | $442,000 |
| Stock Awards | $790,164 |
| Other | $22,403 |
| Total | $1,876,847 |
Kapadia received $790.2K in stock awards, accounting for 42% of the total pay in 2018.
Kapadia also received $228.7K in non-equity incentive plan, $393.5K in option awards, $442K in salary and $22.4K in other compensation.
Rankings
In 2018, Sandip Kapadia's compensation ranked 6,078th out of 14,244 executives tracked by ExecPay. In other words, Kapadia earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,078 out of 14,244 | 57th |
Division Manufacturing | 2,318 out of 5,759 | 60th |
Major group Chemicals And Allied Products | 867 out of 2,122 | 59th |
Industry group Drugs | 726 out of 1,811 | 60th |
Industry Pharmaceutical Preparations | 565 out of 1,385 | 59th |
Pay ratio
| Sandip Kapadia's Pay | $1,876,847 |
|---|---|
| Median Employee's Pay | $244,883 |
| Pay Ratio | 8to 1 |
In 2018, the annual total compensation of Sandip Kapadia was $1,876,847.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $244,883.
The ratio of Sandip Kapadia's pay to the pay of median employee was therefore 8 to one.
Kapadia's colleagues
We found four more compensation records of executives who worked with Sandip Kapadia at Intercept Pharmaceuticals in 2018.
News
May 2, 2022
April 8, 2022
April 27, 2021
April 29, 2020
April 30, 2019